Christopher Henderson
Oprichter bij Anagenesis Biotechnologies SAS
Oorsprong van het eerstegraads netwerk van Christopher Henderson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
124
| Public Company | Pharmaceuticals: Major | 124 |
Anagenesis Biotechnologies SAS
 Anagenesis Biotechnologies SAS Medical/Nursing ServicesHealth Services Anagenesis Biotechnologies SAS operates as a preclinical-stage stem cell-based company. It focuses on developing novel treatments for genetic and age-related muscle degenerative diseases with unmet medical needs. The firm offers cell therapy for genetic diseases and pharmacological drugs for genetic and age-related diseases. The company was founded by Jean-Yves Bonnefoy, Christopher Henderson, Thierry Noel, Olivier Pourquié, Marie Knockaert and Jérôme Chal on April 25, 2011 and is headquartered in Graffenstaden, France.
8
| Holding Company | Medical/Nursing Services | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christopher Henderson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Comptroller/Controller/Auditor | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Founder | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Comptroller/Controller/Auditor Director of Finance/CFO Chief Executive Officer Director/Board Member | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Graduate Degree | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Chief Executive Officer Chief Operating Officer Human Resources Officer | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Massachusetts | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Director/Board Member Graduate Degree | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Public Communications Contact | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member President Chief Operating Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Director/Board Member Corporate Officer/Principal | |
| BIOVERATIV INC | Biotechnology | Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Michigan | College/University | Masters Business Admin Masters Business Admin | |
| Georgetown University | College/University | Director/Board Member Doctorate Degree | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree | |
| Boston University School of Law | College/University | Graduate Degree Graduate Degree | |
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin | |
| NEUROSENSE THERAPEUTICS LTD. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ZAI LAB LIMITED | Biotechnology | Director/Board Member Compliance Officer | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | President Sales & Marketing | |
| EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| VISTERRA INC | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Undergraduate Degree Undergraduate Degree | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| The California State University | College/University | Undergraduate Degree Graduate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Founder Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Ierland | 2 |
| Verenigd Koninkrijk | 2 |
| Frankrijk | 2 |
| Israël | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 15 |
| Finance | 3 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 278 |
| Corporate Officer/Principal | 209 |
| Undergraduate Degree | 76 |
| Independent Dir/Board Member | 64 |
| President | 59 |
Sterkste connecties
| Insiders | |
|---|---|
| William Hawkins | 49 |
| George Scangos | 33 |
| Steven Holtzman | 28 |
| Douglas Williams | 25 |
| Timothy Harris | 19 |
| Joanne Viney | 18 |
| Robin Kramer | 17 |
| Lynne Sullivan | 16 |
| Adriana Karaboutis | 16 |
| Kevin Koch | 15 |
| Michael Ehlers | 15 |
| Spyridon Artavanis-Tsakonas | 15 |
| John Cox | 15 |
| Tony Kingsley | 14 |
| David W Miller | 14 |
- Beurs
- Insiders
- Christopher Henderson
- Bedrijfsconnecties
